Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 CELYAD SA/ADRNorthwest BiotherapeuticsAraviveNuCanaMustang Bio
SymbolNASDAQ:CYADOTCMKTS:NWBONASDAQ:ARAVNASDAQ:NCNANASDAQ:MBIO
Price Information
Current Price$7.42$0.16$5.94$5.30$2.73
52 Week RangeBuyN/ABuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyN/ABuyBuyBuy
Consensus Price Target$27.33N/A$26.00$18.67$7.00
% Upside from Price Target268.37% upsideN/A337.71% upside252.20% upside156.41% upside
Trade Information
Market Cap$104.33 million$103.29 million$80.64 million$163.07 million$106.25 million
Beta1.251.312.41.391.76
Average Volume16,4591,427,951154,164136,863300,392
Sales & Book Value
Annual Revenue$10,000.00$2.41 million$4.75 millionN/AN/A
Price / Sales10,343.4842.8618.78N/AN/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$3.67 per share($0.07) per share$4.71 per share$2.52 per share$1.25 per share
Price / Book2.02-2.241.26N/AN/A
Profitability
Net Income$-32,070,000.00$-20,300,000.00$-18,220,000.00$-27,340,000.00$-46,390,000.00
EPS($2.57)N/A($1.57)($0.84)($1.29)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-842.16%N/AN/AN/A
Return on Equity (ROE)N/AN/A-32.47%-30.37%-86.70%
Return on Assets (ROA)N/A-138.90%-25.70%-27.90%-61.77%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.07%N/A0.11%0.01%0.27%
Current Ratio3.59%0.08%13.73%10.54%8.12%
Quick Ratio3.59%0.08%13.73%10.54%8.12%
Ownership Information
Institutional Ownership Percentage7.84%0.03%42.87%41.76%21.61%
Insider Ownership PercentageN/A27.80%39.80%N/A1.70%
Miscellaneous
EmployeesN/A14142138
Shares Outstanding13.94 million660.01 million15.02 million32.23 million42.84 million
Next Earnings DateN/A5/8/2020 (Estimated)5/13/2020 (Estimated)5/12/2020 (Estimated)5/8/2020 (Estimated)
OptionableNot OptionableNot OptionableOptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel